Eurocastle Investment Limited
Eurocastle announces Director/PDMR Dealing Notification
Eurocastle announces Director/PDMR Dealing Notification
EUROCASTLE INVESTMENT LIMITED
FOR IMMEDIATE RELEASE
Contact:
Oak Fund Services (Guernsey) Limited
Company Administrator
Attn: Nicole Barnes
Tel: +44 1481 752957
Eurocastle Announces Director/PDMR Dealing Notification
Guernsey, 02 December 2025 - By reference to its obligations under Article 19 of EU Regulation 596/2014, Eurocastle Investment Limited is making public the following details of dealings in its shares by persons discharging managerial responsibilities and their closely associated persons:
| Name of PDMR | Financial Instrument | Nature of Transaction | Date and place of Transaction | Volume and price of Transaction |
| Mr. Jason de Beauvoir Sherwill | Ordinary Shares | Purchase of shares | 27 November 2025 | 1,000 shares at EUR 14.80 |
ABOUT EUROCASTLE
Eurocastle Investment Limited (“Eurocastle” or the “Company”) is a publicly traded closed-ended investment company. On 8 July 2022, the Company announced the relaunch of its investment activity and is currently in the early stages of pursuing its new strategy by initially focusing on opportunistic real estate in Greece with a plan to expand across Southern Europe. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Turntide Technologies2.12.2025 15:30:00 CET | Press release
Turntide Powers Dust Moto Electric Motorcycles with Inverter Technology
Benevity2.12.2025 15:30:00 CET | Press release
Benevity Integrates its Trusted Global Nonprofit Network with Anthropic’s Claude for Nonprofits to Accelerate Social Impact
Multiverse Computing2.12.2025 15:00:00 CET | Press release
Multiverse Computing and Cerebrium Bring Compressed AI to the Cloud, Creating a Blueprint for Economically Sustainable AI at Scale
eXp Realty2.12.2025 15:00:00 CET | Press release
eXp Realty Expands Into Two New European Markets and Plans a Third, Marking a Significant Year of Global Growth
BetaGlue Therapeutics SpA2.12.2025 15:00:00 CET | Press release
BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom